ESR1 and breast cancer: Based on the structure of raloxifene, Grese and coworkers [16] synthesized and evaluated a series of 2-arylbenzothiophene derivatives as ligands of the ERα and as inhibitors of the MCF-7 breast cancer cell proliferation in vitro.